Related references
Note: Only part of the references are listed.miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway
Chenyang Zhao et al.
RNA BIOLOGY (2015)
CD44 acts as a signaling platform controlling tumor progression and metastasis
Veronique Orian-Rousseau
FRONTIERS IN IMMUNOLOGY (2015)
CD44 functions in Wnt signaling by regulating LRP6 localization and activation
M. Schmitt et al.
CELL DEATH AND DIFFERENTIATION (2015)
Bone tissue remodeling and development: Focus on matrix metalloproteinase functions
Katiucia Batista Silva Paiva et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Regulation of cortical and trabecular bone mass by communication between osteoblasts, osteocytes and osteoclasts
Natalie A. Sims et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Osteopontin Has a Crucial Role in Osteoclast-Like Multinucleated Giant Cell Formation
Yukiko Oh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
High molecular weight hyaluronic acid regulates osteoclast formation by inhibiting receptor activator of NF-κB ligand through Rho kinase
W. Ariyoshi et al.
OSTEOARTHRITIS AND CARTILAGE (2014)
miR-214 targets ATF4 to inhibit bone formation
Xiaogang Wang et al.
NATURE MEDICINE (2013)
Membrane Localization of Membrane Type 1 Matrix Metalloproteinase by CD44 Regulates the Activation of Pro-Matrix Metalloproteinase 9 in Osteoclasts
Meenakshi A. Chellaiah et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD) MODULATION OF MATRIX METALLOPROTEINASE 9 (MMP-9) TRANSCRIPTION VIA NOVEL PROMOTER RESPONSE ELEMENT
Karl E. Miletti-Gonzalez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Osteopontin Signals through Calcium and Nuclear Factor of Activated T Cells (NFAT) in Osteoclasts A NOVEL RGD-DEPENDENT PATHWAY PROMOTING CELL SURVIVAL
Natsuko Tanabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Differential Use of Chondroitin Sulfate to Regulate Hyaluronan Binding by Receptor CD44 in Inflammatory and Interleukin 4-activated Macrophages
Brian Ruffell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Blood-Derived Human Osteoclast Resorption Activity Is Impaired by Hyaluronan-CD44 Engagement via a p38-Dependent Mechanism
Eliana Pivetta et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Margot Zoeller
NATURE REVIEWS CANCER (2011)
Galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway
Rena Tanikawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Osteopontin is required for unloading-induced osteoclast recruitment and modulation of RANKL expression during tooth drift-associated bone remodeling, but not for super-eruption
Cameron G. Walker et al.
BONE (2010)
Hyaluronan Inhibits Prostaglandin E2 Production via CD44 in U937 Human Macrophages
Tadashi Yasuda
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2010)
NF-κB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism
Zhenqiang Yao et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
NF-κB p50 and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1
Teruhito Yamashita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The molecular understanding of osteoclast differentiation
Masataka Asagiri et al.
BONE (2007)
Hyaluronan inhibits osteoclast differentiation via toll-like receptor 4
Eun-Ju Chang et al.
JOURNAL OF CELL SCIENCE (2007)
Function and regulation of osteopontin in response to mechanical stress
Shinji Fujihara et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
The intracellular domain of CD44 promotes the fusion of macrophages
WG Cui et al.
BLOOD (2006)
Hyaluronan increases RANKL expression in bone marrow strornal cells through CD44
JJ Cao et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Suramin interacts with RANK and inhibits RANKL-induced osteoclast differentiation
A Regmi et al.
BONE (2005)
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation
F Ikeda et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: Evidence of a role for an intracellular form of osteopontin
BQ Zhu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo
E Jimi et al.
NATURE MEDICINE (2004)
Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo
M Morinobu et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
The integrin αvβ3 and CD44 regulate the actions of osteopontin on osteoclast motility
MA Chellaiah et al.
CALCIFIED TISSUE INTERNATIONAL (2003)
Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression
MA Chellaiah et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9
P Spessotto et al.
JOURNAL OF CELL BIOLOGY (2002)
Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts
K Suzuki et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
NF-κB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis
LP Xing et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Resistance to unloading-induced three-dimensional bone loss in osteopontin-deficient mice
M Ishijima et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity
S Yaccoby et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway
I Okamoto et al.
JOURNAL OF CELL BIOLOGY (2001)